Used in the synthesis of prostaglandin analogs, particularly in ophthalmic medications for treating glaucoma. It serves as a key chiral intermediate in the production of drugs that reduce intraocular pressure by increasing uveoscleral outflow of aqueous humor. Its cyclopropyl structure with a hydroxymethyl group enables selective biological activity and metabolic stability, making it valuable in developing long-acting eye drops. Also employed in research for optimizing prostaglandin-based therapeutics due to its favorable stereochemistry and lipophilicity.